686 related articles for article (PubMed ID: 9685397)
1. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
2. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
3. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
4. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
5. Involvement of ErbB2 in the signaling pathway leading to cell cycle progression from a truncated epidermal growth factor receptor lacking the C-terminal autophosphorylation sites.
Sasaoka T; Langlois WJ; Bai F; Rose DW; Leitner JW; Decker SJ; Saltiel A; Gill GN; Kobayashi M; Draznin B; Olefsky JM
J Biol Chem; 1996 Apr; 271(14):8338-44. PubMed ID: 8626530
[TBL] [Abstract][Full Text] [Related]
6. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE
Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245
[TBL] [Abstract][Full Text] [Related]
7. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions.
Pelicci G; Dente L; De Giuseppe A; Verducci-Galletti B; Giuli S; Mele S; Vetriani C; Giorgio M; Pandolfi PP; Cesareni G; Pelicci PG
Oncogene; 1996 Aug; 13(3):633-41. PubMed ID: 8760305
[TBL] [Abstract][Full Text] [Related]
8. Functional importance of amino-terminal domain of Shc for interaction with insulin and epidermal growth factor receptors in phosphorylation-independent manner.
Sasaoka T; Ishihara H; Sawa T; Ishiki M; Morioka H; Imamura T; Usui I; Takata Y; Kobayashi M
J Biol Chem; 1996 Aug; 271(33):20082-7. PubMed ID: 8702728
[TBL] [Abstract][Full Text] [Related]
9. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.
van der Geer P; Wiley S; Gish GD; Pawson T
Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605
[TBL] [Abstract][Full Text] [Related]
10. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction.
Yajnik V; Blaikie P; Bork P; Margolis B
J Biol Chem; 1996 Jan; 271(4):1813-6. PubMed ID: 8567619
[TBL] [Abstract][Full Text] [Related]
11. Activation of the Ras/mitogen-activated protein kinase pathway by kinase-defective epidermal growth factor receptors results in cell survival but not proliferation.
Walker F; Kato A; Gonez LJ; Hibbs ML; Pouliot N; Levitzki A; Burgess AW
Mol Cell Biol; 1998 Dec; 18(12):7192-204. PubMed ID: 9819406
[TBL] [Abstract][Full Text] [Related]
12. N-Shc: a neural-specific adapter molecule that mediates signaling from neurotrophin/Trk to Ras/MAPK pathway.
Nakamura T; Sanokawa R; Sasaki Y; Ayusawa D; Oishi M; Mori N
Oncogene; 1996 Sep; 13(6):1111-21. PubMed ID: 8808684
[TBL] [Abstract][Full Text] [Related]
13. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B
J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035
[TBL] [Abstract][Full Text] [Related]
14. Insulin receptor substrate-1 enhances growth hormone-induced proliferation.
Liang L; Zhou T; Jiang J; Pierce JH; Gustafson TA; Frank SJ
Endocrinology; 1999 May; 140(5):1972-83. PubMed ID: 10218944
[TBL] [Abstract][Full Text] [Related]
15. The PI/PTB domain: a new protein interaction domain involved in growth factor receptor signaling.
Margolis B
J Lab Clin Med; 1996 Sep; 128(3):235-41. PubMed ID: 8783629
[TBL] [Abstract][Full Text] [Related]
16. Differential utilization of ShcA tyrosine residues and functional domains in the transduction of epidermal growth factor-induced mitogen-activated protein kinase activation in 293T cells and nerve growth factor-induced neurite outgrowth in PC12 cells. Identification of a new Grb2.Sos1 binding site.
Thomas D; Bradshaw RA
J Biol Chem; 1997 Aug; 272(35):22293-9. PubMed ID: 9268379
[TBL] [Abstract][Full Text] [Related]
17. Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of Shc.
Zhou MM; Harlan JE; Wade WS; Crosby S; Ravichandran KS; Burakoff SJ; Fesik SW
J Biol Chem; 1995 Dec; 270(52):31119-23. PubMed ID: 8537373
[TBL] [Abstract][Full Text] [Related]
18. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins.
Kavanaugh WM; Williams LT
Science; 1994 Dec; 266(5192):1862-5. PubMed ID: 7527937
[TBL] [Abstract][Full Text] [Related]
19. A differential requirement for the COOH-terminal region of the epidermal growth factor (EGF) receptor in amphiregulin and EGF mitogenic signaling.
Wong L; Deb TB; Thompson SA; Wells A; Johnson GR
J Biol Chem; 1999 Mar; 274(13):8900-9. PubMed ID: 10085134
[TBL] [Abstract][Full Text] [Related]
20. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation.
Song RX; McPherson RA; Adam L; Bao Y; Shupnik M; Kumar R; Santen RJ
Mol Endocrinol; 2002 Jan; 16(1):116-27. PubMed ID: 11773443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
